Compare Mesoblast Limited (MESO) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Tractor Supply Co — how do they compare? Mesoblast Limited trades at $13.8 (market cap $1.75B), while Tractor Supply Co trades at $33.5 (market cap $17.44B). The key difference: Tractor Supply Co is far larger — about 10× Mesoblast Limited's market cap, and Tractor Supply Co pays a 2.87% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 14 Days and Tractor Supply Co for 88 Days on average.
| MESO | TSCO | |
|---|---|---|
Market Cap | $1.75B | $17.44B |
Volume | 239,027 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $20.96 | $56.37 |
52-Week Low | $13.19 | $29.14 |
Typical Hold Time | 14 Days | 88 Days |
Enterprise Value | $1.83B | $23.76B |
Dividend Yield | — | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.
While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.
Tractor Supply (TSCO) trades at $32.52, up 0.71% today, with a bullish technical signal from moving averages. The company reported revenue growth to $15.52B in 2025, but net income margin has declined to 6.42%, and it missed earnings estimates for three consecutive quarters. Recent news highlights community initiatives and a new distribution center opening, while some institutional investors reduced positions.
Outlook is mixed: analyst consensus is a Buy with a $36.76 price target, but earnings misses and margin pressure pose risks. The dividend streak remains a positive, yet competitive and cyclical headwinds require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
